Trial Profile
Assessing the Effects of Switching Therapy from Clopidogrel to Prasugrel in Patients with Acute Coronary Syndrome Already Treated with Clopidogrel
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Mar 2014
Price :
$35
*
At a glance
- Drugs Prasugrel (Primary)
- Indications Acute coronary syndromes; Ischaemic heart disorders; Thrombosis
- Focus Therapeutic Use
- Acronyms SWITCH
- 10 Mar 2014 New trial record